We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SPCE:NYSEVirgin Galactic Holdings, Inc. Analysis

Data as of 2026-09-12 - not real-time

$2.92

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Virgin Galactic Holdings, Inc. trades at $2.92, with its moving averages tangled rather than clearly stacked — a neutral trend structure. Across the trailing 30 sessions it gained 14.1%. With RSI at 47.1 the momentum picture is neutral, alongside a bearish MACD signal. Watch $2.85 as support and $3.47 as the nearer resistance level.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. The average analyst target implies 21.9% above today's level. Revenue is contracting at 67.0%.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 56.8%, a beta of 2.21 and a maximum drawdown of 67.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
All three time horizons resolve to hold, carrying 2/10 conviction.

Top Market Events

Virgin Galactic Holdings Inc. NYSE: SPCE touted a path to nearly $1 billion in annual revenue as it scales its fleet...Benzinga.com1monVirgin Galactic Holdings Earnings & ForecastsVirgin Galactic Holdings SPCE last issued guidance on May...Virgin Galactic Holdings Inc SPCE posted its second-quarter results after Wednesday’s closing bell.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Trading below the 200-day average of 3.03
  • MACD momentum is negative
  • 30-day price change of +14.1%

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • Trading below the 200-day average of 3.03
  • Analyst targets imply +21.9% versus the current price
  • 30-day volatility of 56.8%

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • Analyst targets imply +21.9% versus the current price
  • Negative return on equity of -75.1%
  • Revenue contracting at -67.0%

Key Metrics & Analysis

Financial Health

Revenue Growth-67.00%
P/E Ratio-4.7
ROE-75.13%
ROA-18.98%
Debt/Equity66.98
P/B Ratio1.0
Op. Cash Flow$-212451008
Free Cash Flow$-295968000
Industry P/E28.0

Technical Analysis

TrendNeutral
RSI47.1
Support$2.85
Resistance$3.47
MA 20$3.03
MA 50$2.85
MA 200$3.03
MACDBearish
VolumeDecreasing
Fear & Greed Index93.14

Valuation

Target Price$3.56
Upside/Downside21.92%
GradeFair
TypeBlend

Risk Assessment

Beta2.21
Volatility56.83%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.